gip glp 1 tirzepatide Tirzepatide, a dual GIP/GLP-1 receptor co-agonist for the treatment of type 2 diabetes with unmatched effectiveness regrading glycaemic control and body weight reduction | Cardiovascular Diabetology Tirzepatide vs. Semaglutide: What You

(PubMed) Schmuth M, Wimmer MA, Hofer S, et al

Cardiovascular outcome studies Although multiple clinical trials evaluating cardiovascular events associated with GLP-1 RA use as the primary outcome are currently ongoing (Table 1), abundant non-primary outcome data are available from many clinical trials on the efficacy of GLP-1 RAs marketed earlier, such as exenatide (DURATION studies) and liraglutide (LEAD studies)

I mean I've seen studies

In 2020, Zmitek et al

Used as Needed Rather Than Daily Most PT 141 protocols are used as needed before intimacy rather than as a daily peptide, which makes it convenient and cost effective